30JUN

Welcome To Mediterr J Med Med Sci

Manuscripts are accepted for consideration with the understanding that they represent original material and are not being considered for publication elsewhere. The editors welcome the submission of relevant articles for editorial consideration. Manuscripts and all scientific and professional data should be addressed to the Editor-in-Chief (fmosherif@yahoo.com, f.sherif@uot.edu.ly).

Mediterranean Journal of Medicine and Medical Sciences
https://mmj.org.ly/article/doi/10.5281/zenodo.21834274

Mediterranean Journal of Medicine and Medical Sciences

Original article Healthcare

Willingness and barriers to COVID-19 vaccination among Libyan adults: A cross-sectional survey

Mustafa A. Alssageer, Khadeja M. Mohammed, Nour Alhoda E. Masoud

Downloads: 0
Views: 12

Abstract

The success of COVID-19 vaccination programs depends on public acceptance, yet evidence from southern Libya remains limited. This study aimed to examine public perceptions, attitudes, and willingness toward COVID-19 vaccination among adults in urban and rural areas of southern Libya. A cross-sectional survey of adults in Sebha and the surrounding areas was conducted. Data were analysed using descriptive statistics and chi-square tests. A total of 785 questionnaires were distributed, of which 689 were completed and returned, yielding a response rate of 87.8%. The internet was the most commonly reported source of information about COVID-19 vaccination (58.2%), followed by television (25.4%). Overall, 64.6% of participants expressed willingness to receive the COVID-19 vaccine, while 35.4% were unwilling. Vaccine willingness was significantly associated with age group, marital status, place of residence, and education level. The most common reasons for acceptance were protection against COVID-19 infection (33.0%), free vaccine availability (20.0%), and prevention of transmission to others (15.8%). Among those who refused, the leading reason was concern about vaccine safety and/or side effects (50.0%), followed by preference to wait and observe effects in others (14.3%), doubts about effectiveness (10.3%), and general vaccine distrust (9.9%). Regarding opinions, 50.4% agreed that COVID-19 vaccination was important, 50.9% agreed that everyone should receive the vaccine once it is available, and 37.3% supported mandatory vaccination. This study reveals moderate willingness to receive COVID-19 vaccines among adults in southern Libya, with safety concerns and mistrust as key barriers. Targeted campaigns that engage healthcare professionals and counter misinformation are urgently needed. Importantly, these barriers extend beyond COVID-19, affecting routine and future vaccinations. Given Libya's fragile health system, these efforts must be integrated into a comprehensive national immunization plan to build sustainable vaccine confidence and resilience in the health system.

Keywords

COVID19, coronavirus vaccine, perceptions and attitudes, Sebha, Southwestern Libya

References

  1. Lone SA, Ahmad A. COVID-19 pandemic - an African perspective. Emerging Microbes and Infections. 2020; 9(1): 1300-1308. doi:  10.1080/22221751.2020.1775132
  2. Moore M, Gelfeld B, Okunogbe A, Paul C. Identifying future disease hot spots: Infectious disease vulnerability index, Rand Health Quarterly. 2017; 6(3): 5. PMID: 28845357; PMCID: PMC5568150.
  3. Centers for Disease Control and Prevention. Ten great public health achievements-United States, 1900-1999. Morbidity and Mortality Weekly Report. 1999; 48(12): 241-243. PMID: 10220250.
  4. Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bulletin of the World Health Organization. 2008; 86(2): 140-146. doi: 10.2471/blt. 07.040089
  5. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, et al. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)-United States, 1991-2001. Morbidity and Mortality Weekly Report: Surveillance Summaries. 2003; 52(1): 1-24. PMID: 12825543.
  6. Jackson LA, Anderson EJ, Rouphael NG, Roberts PC, Makhene M, Coler RN, et al. An mRNA vaccine against SARS-CoV-2 - Preliminary report. The New England Journal of Medicine. 2020; 383(20): 1920-1931. doi: 10.1056 /NEJMoa2022483
  7. Yuen K-S, Ye Z-W, Fung S-Y, Chan C-P, Jin D-Y. SARS-CoV-2 and COVID-19: The most important research questions. Cell and Bioscience. 2020; 10(40). doi: 10.1186/s13578-020-00404-4
  8. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5
  9. Fauci AS, Lane HC, Redfield RR. COVID-19 - Navigating the uncharted. The New England Journal of Medicine. 2020; 382(13): 1268-1269. doi: 10.1056/NEJMe2002387
  10. Fine P, Eames K, Heymann DL. Herd immunity: A rough guide. Clinical Infectious Diseases. 2011; 52(7): 911-916. doi: 10.1093/cid/cir007
  11. Yoda T, Katsuyama H. Willingness to receive COVID-19 vaccination in Japan. Vaccines. 2021; 9(1): 48. doi: 10.3390/vaccines9010048
  12. Alfageeh EI, Alshareef N, Angawi K, Alhazmi F, Chirwa GC. Acceptability of a COVID-19 vaccine among the Saudi population. Vaccines. 2021; 9(3): 226. doi: 10.3390/vaccines9030226
  13. Syed Alwi SAR, Rafidah E, Zurraini A, Juslina O, Brohi IB, Lukas S. A survey on COVID-19 vaccine acceptance and concern among Malaysians. British Medical Journal: Public Health. 2021; 21(1): 1129. doi: 10.1186/s12889-021-11071-6
  14. Eibensteiner F, Ritschl V, Nawaz FA, Fazel SS, Tsagkaris C, Kulnik ST, et al. People’s willingness to vaccinate against COVID-19 despite their safety concerns: Twitter poll analysis. Journal of Medical Internet Research. 2021; 23(4): e28973. doi: 10.2196/28973
  15. Barry V, Dasgupta S, Weller DL, Kris JL, Cadwell BL, Rose C, et al. Patterns in COVID-19 vaccination coverage, by social vulnerability and urbanicity - United States, December 14, 2020-May 1, 2021. Morbidity and Mortality Weekly Report. 2021; 70(22): 818-824. doi: 10.15585/mmwr.mm7022e1
  16. Wake AD. The willingness to receive COVID-19 vaccine and its associated factors: Vaccination refusal could prolong the war of this pandemic - A systematic review. Risk Management and Healthcare Policy. 2021; 14: 2609-2623. doi: 10.2147/RMHP.S311074
  17. Wang J, Jing R, Lai X, Zhang H, Lyu Y, Knoll MD, Fang H. Acceptance of COVID-19 vaccination during the COVID-19 pandemic in China. Vaccines. 2020; 8(3): 482. doi: 10.3390/vaccines8030482
  18. Abedin M, Islam MA, Rahman FN, Reza HM, Hossain MZ, Rahman MA, et al. Willingness to vaccinate against COVID-19 among Bangladeshi adults. PLoS ONE. 2021; 16(4), e0250495. doi: 10.1371/journal.pone.0250495
  19. Zintel S, Flock C, Arbogast AL, Forster A, von Wagner C, Sieverding M. Gender differences in the intention to get vaccinated against COVID-19: A systematic review and meta-analysis. Zeitschrift für Gesundheitswissenschaften. 2022: 1-25. doi: 10.1007/s10389-021-01677-w
  20. Poland G, Jacobson RM. Understanding those who do not understand: A brief review of the anti-vaccine movement. Vaccine. 2001; 19(17-19): 2440-2445. doi: 10.1016/S0264-410X(00)00469-2
  21. MacDonald NE. Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015; 33(34): 4161-4164. doi: 10.1016/j.vaccine.2015.04.036
  22. Dror AA, Eisenbach N, Taiber S, Morozov NG, Mizrachi M, Zigron A, et al. Vaccine hesitancy: The next challenge in the fight against COVID-19. European Journal of Epidemiology. 2020; 35(8): 775-779. doi: 10.1007/s10654-020-00671-y
  23. Al-Mohaithef M, Padhi BK, Ennaceur SA. Demographics of COVID-19 vaccine hesitancy during the second wave of COVID-19 pandemic: A cross-sectional web-based survey in Saudi Arabia. medRxiv (Preprint). 2021; doi: 10.1101/2021.04.20.21255781
  24. Murphy J, Vallières F, Bentall RP, Shevlin M, McBride O, Hartman TK, et al. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature Communications. 2021; 12(1): 29. doi: 10.1038/s41467-020-20226-9
  25. Al-Mohaithef M, Padhi BK. Determinants of COVID-19 vaccine acceptance in Saudi Arabia: A web-based national survey. Journal of Multidisciplinary Healthcare. 2020; 13: 1657-1663. doi: 10.2147/JMDH.S276771
  26. Wilson SL, Wiysonge C. Social media and vaccine hesitancy. British Medical Journal: Global Health. 2020; 5(10): e004206. doi: 10.1136/bmjgh-2020-004206
  27. Limbu YB, Gautam RK, Pham L. The health belief model applied to COVID-19 vaccine hesitancy: A systematic review. Vaccines (Basel). 2022; 10(6): 973. doi: 10.3390/vaccines10060973
  28. Alhaddad FE, Abuleid KM. Evaluation of adverse effects of AstraZeneca COVID-19 vaccine after the first dose in Libyan adults:a cross-sectional study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(4): 65-69. doi: 10.5281/zenodo.7479778
  29. Omran EAA, Alshebani AMA, Almajdoub OH. Potential risk factors for mortality in patients with COVID-19: A retrospective study. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2022; 2(1): 37-43. doi: 10.5281/zenodo.6399474
  30. Taeb ST, Alamory MM, Alamay ZM, Nafae SSH. Assessing the readiness of community pharmacists in Libya for vaccine administration: Barriers and opportunities. Mediterranean Journal of Pharmacy and Pharmaceutical Sciences. 2025; 5(1): 65-74. doi: 10.5281/zenodo.14695845
  31. Benomran EA, Nagah TAM, Arboleda-Tinay MC, Gusbi NA, El Jali T. An exploration of selected variables as a predictor of COVID-19 vaccination rollouts: A correlational study. Mediterranean Journal of Medical Research. 2026; 3(2): 176-183. doi: 10.5281/zenodo.20467289

Submitted date:
03/08/2026

Reviewed date:
08/23/2026

Accepted date:
08/05/2026

Publication date:
08/04/2026

6a726ff6a953953ecf6880ca mjmmr Articles
Links & Downloads

Mediterr J Med Med Sci

Share this page
Page Sections